Relationship of gene polymorphisms for complement components C3 and factor H and kidney allograft function.

Area of Science:

• Immunogenetics
• Transplantation Immunology
• Renal Medicine

Background:

• Complement system activation is crucial in ischemia/reperfusion injury and allograft rejection.
• Genetic factors may influence kidney transplant outcomes, but specific associations require further investigation.

Purpose of the Study:

• To investigate the association between single nucleotide polymorphisms (SNPs) in complement genes C3 and FH and outcomes in kidney transplant recipients.
• To determine the impact of these genetic variations on delayed graft function (DGF) and long-term allograft function.

Main Methods:

• Retrospective observational study of 73 non-diabetic deceased donor kidney allograft recipients.
• Genotyping for complement component C3 (rs2230199) and Factor H (FH) (rs800292) polymorphisms.
• Analysis of associations between genotypes and outcomes including delayed graft function and creatinine clearance over five years.

Main Results:

• The FH GG genotype was significantly associated with a higher incidence of delayed graft function (p=0.022).
• Recipients with FH GG genotype showed a higher frequency of DGF compared to GA genotype carriers (67.3% vs. 38.1%).
• C3 GC/GG genotypes were linked to significantly lower creatinine clearance at 1, 3, and 5 years post-transplant compared to CC genotype (p<0.010).

Conclusions:

• Complement gene polymorphisms, specifically in FH and C3, are significant determinants of kidney allograft outcomes.
• FH genotype influences early graft function (DGF), while C3 genotype impacts long-term renal function.
• Genetic predisposition plays a critical role in post-transplant renal outcomes, highlighting potential for personalized risk assessment.